Jennifer Rosenthal
Corporate Officer/Principal at VIRALYTICS LTD.
Jennifer Rosenthal active positions
Companies | Position | Start | End |
---|---|---|---|
VIRALYTICS LTD. | Corporate Officer/Principal | - | - |
CLARITY PHARMACEUTICALS LTD | General Counsel | 2019-09-30 | - |
Career history of Jennifer Rosenthal
Former positions of Jennifer Rosenthal
Companies | Position | Start | End |
---|---|---|---|
THE SUSTAINABLE NUTRITION GROUP LTD | Chief Tech/Sci/R&D Officer | 2005-12-31 | - |
Training of Jennifer Rosenthal
Monash University | Doctorate Degree |
Statistics
International
Australia | 5 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Process Industries | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CLARITY PHARMACEUTICALS LTD | Health Technology |
Private companies | 2 |
---|---|
The Sustainable Nutrition Group Pty Ltd.
The Sustainable Nutrition Group Pty Ltd. Agricultural Commodities/MillingProcess Industries The Sustainable Nutrition Group Ltd. produces, manufactures, and distributes a range of hemp products in Australia. It is involved in hemp seed selection, farming, processing, and packaging, as well as distribution and sale of bulk and retail products. The company's products include hand sanitizers, hemp oils, hemp seeds, hemp protein powders, and hemp flour under the APH and Mt Elephant brands to retail, wholesale, and white label customers. The company was founded by James Hood and Tracie Rams dale in 1995 and is headquartered in Newtown, Australia. | Process Industries |
Viralytics Pty Ltd.
Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
- Stock Market
- Insiders
- Jennifer Rosenthal
- Experience